SCM
GRNAW

Shaolin Capital Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Shaolin Capital Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,000
Closed -$77K – 1026
2022
Q1 		$77K Sell
100,000
-137,026
-58% -$100K ﹤0.01% 702
2021
Q4 		$284K Hold
237,026
– – 0.01% 546
2021
Q3 		$239K Buy
+237,026
New +$249K 0.01% 433

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Shaolin Capital Management's GRNAW Position: Q2 2022 in Review

Shaolin Capital Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q2 2022, closing a stake of 100,000 shares — an estimated $77K sold.

Shaolin Capital Management first reported a position in GRNAW in Q3 2021 and held it in 3 quarters. The position peaked at $284K in Q4 2021. 21 funds tracked by Wall St. Rank hold GRNAW as of Q2 2022.

  • Shaolin Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q2 2022 after selling out during the quarter.
  • Shaolin Capital Management sold 100,000 GreenLight Biosciences Holdings, PBC Warrant shares in Q2 2022, an estimated $77K.
  • Shaolin Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q3 2021 and held it in 3 quarters.
  • Shaolin Capital Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $284K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q2 2022.

Based on Shaolin Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.